Nishant Agrawal1, Maria R Evasovich2, Emad Kandil3, Salem I Noureldine4, Erin A Felger5, Ralph P Tufano6, Dennis H Kraus7, Lisa A Orloff8, Raymon Grogan9, Peter Angelos9, Brendan C Stack10, Bryan McIver11, Gregory W Randolph12. 1. Department of Surgery, Section of Otolaryngology - Head and Neck Surgery, University of Chicago, Chicago, Illinois. 2. Department of Surgery, University of Minnesota School of Medicine, Minneapolis, Minnesota. 3. Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana. 4. Department of Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC. 5. Department of Surgery, Washington Hospital Center, Washington, DC. 6. Department of Otolaryngology - Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland. 7. Center for Head and Neck Oncology, New York Head and Neck Institute, Northwell Health Cancer Institute, New York, New York. 8. Department of Otolaryngology, Stanford University Medical Center, Stanford, California. 9. Department of Surgery, Section of Endocrine Surgery, University of Chicago, Chicago, Illinois. 10. Department of Otolaryngology - Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas. 11. Department of Head and Neck Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida. 12. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
Abstract
BACKGROUND: The primary purposes of this interdisciplinary consensus statement were to review the relevant indications for central neck dissection (CND) in patients with papillary thyroid cancer (PTC) and to outline the appropriate extent and relevant techniques required to accomplish a safe and effective CND. METHODS: A writing group convened by the American Head and Neck Society (AHNS) Endocrine Committee was tasked with identifying the important clinical elements to consider when managing the central neck compartment in patients with PTC based on available evidence in the literature, and the group's collective experience. The position statement paper was then submitted to the full Endocrine Committee, Education Committee, and AHNS Council. RESULTS: This consensus statement was developed to inform the clinical decision-making process when managing the central neck compartment in patients with PTC from the AHNS. This document is intended to provide clarity through definitions as well as a basic guideline from which to manage the central neck. It is our hope that this improves the quality and reduces variation in management of the central neck, facilitates communication, and furthers research for patients with thyroid cancer. CONCLUSION: This represents, in our opinion, contemporary optimal surgical care for this patient population and is endorsed by the American Head and Neck Society.
BACKGROUND: The primary purposes of this interdisciplinary consensus statement were to review the relevant indications for central neck dissection (CND) in patients with papillary thyroid cancer (PTC) and to outline the appropriate extent and relevant techniques required to accomplish a safe and effective CND. METHODS: A writing group convened by the American Head and Neck Society (AHNS) Endocrine Committee was tasked with identifying the important clinical elements to consider when managing the central neck compartment in patients with PTC based on available evidence in the literature, and the group's collective experience. The position statement paper was then submitted to the full Endocrine Committee, Education Committee, and AHNS Council. RESULTS: This consensus statement was developed to inform the clinical decision-making process when managing the central neck compartment in patients with PTC from the AHNS. This document is intended to provide clarity through definitions as well as a basic guideline from which to manage the central neck. It is our hope that this improves the quality and reduces variation in management of the central neck, facilitates communication, and furthers research for patients with thyroid cancer. CONCLUSION: This represents, in our opinion, contemporary optimal surgical care for this patient population and is endorsed by the American Head and Neck Society.
Authors: Narin N Carmel-Neiderman; Irit Duek; Dana Amsterdam; Anat Wengier; Boris Kuzmenko; Barak Ringel; Anton Warshavsky; Udi Shapira; Gilad Horowitz; Elena Izkhakov; Dan M Fliss Journal: Eur Arch Otorhinolaryngol Date: 2020-06-02 Impact factor: 2.503
Authors: Fabio Medas; Ernico Erdas; Gian Luigi Canu; Alessandro Longheu; Giuseppe Pisano; Massimiliano Tuveri; Pietro Giorgio Calò Journal: J Otolaryngol Head Neck Surg Date: 2018-01-22
Authors: Peter Zbären; Jatin P Shah; Gregory W Randolph; Carl E Silver; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Luiz P Kowalski; Carlos Suarez; Alvaro Sanabria; Vincent Vander Poorten; Iain Nixon; Alessandra Rinaldo; Alfio Ferlito Journal: Adv Ther Date: 2019-08-10 Impact factor: 3.845